A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)

In by ECIR

Locations
Macon
Condition
Diabetes

A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)

  • Hidden
  • This field is for validation purposes and should be left unchanged.
clinicaltrials.gov

Eligibility

Inclusion Criteria
  1. Male or Female ≥ 18 years of age
  2. Multiple daily injection (MDI) therapy with insulin glargine (U-100) and rapid-acting insulin
  3. A1c 7.5-10%
  4. BMI ≤ 40 kg/m2
  5. May be treated up to ≤ 3 of the following:
    • Metformin
    • DPP-4 inhibitor
    • SGLT2 inhibitor
    • GLP-1 RA
Exclusion Criteria
  1. T1DM
  2. History of HSS or DKA or severe hypoglycemia within 6 months
  3. >2 units/kg insulin TDD
  4. SCr >2, ESRD, or renal transplant
  5. History of stroke, MI, CAD, or CABG within 6 months
  6. HF NYHA Class III and IV
Back to Current Studies